HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.

Abstract
Mucosal candidiasis is frequent in immunocompromised HIV-infected highly active antiretroviral (HAART) naive patients or those who have failed therapy. Mucosal candidiasis is a marker of progressive immune deficiency. Because of the frequently marked and prompt immune reconstitution induced by HAART, there is no recommendation for primary antifungal prophylaxis of mucosal candidiasis in the HIV setting in Europe, although it has been evidenced as effective in the pre-HAART era. Fluconazole remains the first line of therapy for both oropharyngeal candidiasis and oesophageal candidiasis and should be preferred to itraconazole oral solution (or capsules when not available) due to fewer side effects. For patients who still present with fluconazole-refractory mucosal candidiasis, oral treatment with any other azole should be preferred based on precise Candida species identification and susceptibility testing results in addition to the optimization of HAART when feasible. For vaginal candidiasis, topical therapy is preferred.
AuthorsO Lortholary, G Petrikkos, M Akova, M C Arendrup, S Arikan-Akdagli, M Bassetti, J Bille, T Calandra, E Castagnola, O A Cornely, M Cuenca-Estrella, J P Donnelly, J Garbino, A H Groll, R Herbrecht, W W Hope, H E Jensen, B J Kullberg, C Lass-Flörl, W Meersseman, M D Richardson, E Roilides, P E Verweij, C Viscoli, A J Ullmann, ESCMID Fungal Infection Study Group
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 18 Suppl 7 Pg. 68-77 (Dec 2012) ISSN: 1469-0691 [Electronic] England
PMID23137138 (Publication Type: Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.
Chemical References
  • Antifungal Agents
Topics
  • Antifungal Agents (therapeutic use)
  • Antiretroviral Therapy, Highly Active
  • Candida (drug effects, isolation & purification)
  • Candidiasis (complications, diagnosis, drug therapy, prevention & control)
  • Evidence-Based Medicine (standards)
  • HIV Infections (complications)
  • Humans
  • Immunocompromised Host

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: